Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...

Sequencing bacterial genomes allows scientists to study bacterial diversity, immunity, and the human microbiome, but it ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

The CRISPR-Cas9 system offers groundbreaking genome editing capabilities, yet off-target cleavage raises concerns about ...

Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) ...

A study published in Nature Communications and conducted by researchers from the Institute of Physics of the Chinese Academy of Sciences revealed new ...

Dr. Krishna Maharjan studies chromosomes and cell structures. One of Nepal’s leading cytogeneticists, he broadened my ...

CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target hoisted by Barclays from $55.00 to $56.00 in a note ...

Researchers developed an epigenetic editing approach to silence the PCSK9 gene, achieving long-term cholesterol reduction ...

Applied DNA Sciences Inc (APDN) reports increased revenues and strategic shifts, while addressing financial hurdles and ...